136 related articles for article (PubMed ID: 33887578)
1. Immunotherapeutic strategy based on anti-OX40L and low dose of IL-2 to prolong graft survival in sensitized mice by inducing the generation of CD4
Wang F; Wang S; He B; Liu H; Wang X; Li C; Peng P; Zhao J; Zang Y
Int Immunopharmacol; 2021 Aug; 97():107663. PubMed ID: 33887578
[TBL] [Abstract][Full Text] [Related]
2. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
3. An immunotherapeutic strategy for prolonging graft survival in mice.
Wang F; Li J; Wang D; Fu Q; Xiong YY; Huang HT; Liu LS; Wang CX
Transpl Immunol; 2015 Oct; 33(2):84-94. PubMed ID: 26319678
[TBL] [Abstract][Full Text] [Related]
4. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice.
Minamimura K; Sato K; Yagita H; Tanaka T; Arii S; Maki T
Am J Transplant; 2008 Apr; 8(4):761-72. PubMed ID: 18261171
[TBL] [Abstract][Full Text] [Related]
5. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
Front Immunol; 2019; 10():306. PubMed ID: 30863408
[TBL] [Abstract][Full Text] [Related]
6. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
9. Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells.
Dai Z; Zhang S; Xie Q; Wu S; Su J; Li S; Xu Y; Li XC
Am J Transplant; 2014 Jan; 14(1):39-48. PubMed ID: 24219162
[TBL] [Abstract][Full Text] [Related]
10. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
Wang X; Wang W; Xu J; Le Q
Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
[TBL] [Abstract][Full Text] [Related]
11. Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.
Pilon CB; Petillon S; Naserian S; Martin GH; Badoual C; Lang P; Azoulay D; Piaggio E; Grimbert P; Cohen JL
Am J Transplant; 2014 Dec; 14(12):2874-82. PubMed ID: 25394722
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
[TBL] [Abstract][Full Text] [Related]
13. Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.
Tsuda H; Su CA; Tanaka T; Ayasoufi K; Min B; Valujskikh A; Fairchild RL
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467328
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting accelerated rejection mediated by alloreactive CD4(+) memory T cells and prolonging allograft survival by 1α,25-dihydroxyvitamin D(3) in nude mice.
Yan G; Xi Y; Xu S; Chen J; Lin Y; Dai H; Cheng P; Xiao H; Liu Z; Qi Z
Immunol Lett; 2013 Jan; 149(1-2):54-61. PubMed ID: 23147102
[TBL] [Abstract][Full Text] [Related]
16. A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model.
D'Addio F; Yuan X; Habicht A; Williams J; Ruzek M; Iacomini J; Turka LA; Sayegh MH; Najafian N; Ansari MJ
Transplantation; 2010 Aug; 90(3):260-9. PubMed ID: 20712076
[TBL] [Abstract][Full Text] [Related]
17. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
18. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin generates graft-homing murine suppressor CD8(+) T cells that confer donor-specific graft protection.
El Essawy B; Putheti P; Gao W; Strom TB
Cell Transplant; 2011; 20(11-12):1759-69. PubMed ID: 21439133
[TBL] [Abstract][Full Text] [Related]
20. Defective CD8 Signaling Pathways Delay Rejection in Older Recipients.
Bedi DS; Krenzien F; Quante M; Uehara H; Edtinger K; Liu G; Denecke C; Jurisch A; Kim I; Li H; Yuan X; Ge X; ElKhal A; Tullius SG
Transplantation; 2016 Jan; 100(1):69-79. PubMed ID: 26356176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
